- Investing Ideas
- /
- French Pharmaceuticals & Biotech High Growth Potential Companies
French Pharmaceuticals & Biotech High Growth Potential Companies
Results
13
1 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDCL | €13.50 | -7.2% | 49.8% | €401.7m | €22.23 | PS30.4x | E114.3% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
ADOC | €4.97 | -8.6% | -50.2% | €78.7m | €6.30 | PS21.9x | E64.0% | n/a | ||
AELIS | €1.98 | -8.3% | -85.3% | €27.0m | €9.10 | PS2.5x | E33.8% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
GNFT | €3.65 | -6.4% | 8.1% | €182.0m | €9.45 | PE8.2x | E45.2% | n/a | ||
IPH New | €2.10 | 9.6% | -10.6% | €176.0m | €6.14 | PS5.2x | E50.9% | n/a | ||
DIM | €208.60 | -2.5% | -17.8% | €20.3b | €240.00 | PE115.9x | E30.6% | 0.3% | ||
ERF | €49.44 | -2.1% | -14.0% | €9.3b | €58.39 | PE26.1x | E18.5% | 1.2% | ||
ALTHX | €0.53 | 2.3% | -28.9% | €4.1m | €6.20 | PS1.8x | E112.8% | n/a | ||
BOI | €24.95 | -0.6% | -30.7% | €433.2m | €33.30 | PE18.3x | E26.2% | 5.4% | ||
ALERS | €25.40 | 0% | 51.2% | €255.1m | €30.00 | PE38.4x | E29.0% | n/a | ||
IVA | €2.42 | 8.0% | -20.4% | €231.5m | €7.10 | PS12x | E31.7% | n/a |
Page 1 of 1